BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9718226)

  • 1. An international evaluation of the cancer preventive potential of carotenoids.
    Vainio H; Rautalahti M
    Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):725-8. PubMed ID: 9718226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative absorption and transport of five common carotenoids in preruminant calves.
    Bierer TL; Merchen NR; Erdman JW
    J Nutr; 1995 Jun; 125(6):1569-77. PubMed ID: 7782912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
    Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-carotene, carotenoids, and disease prevention in humans.
    Mayne ST
    FASEB J; 1996 May; 10(7):690-701. PubMed ID: 8635686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer chemoprevention by supplemental carotenoids in animals and humans.
    Santamaria L; Bianchi A
    Prev Med; 1989 Sep; 18(5):603-23. PubMed ID: 2694158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific serum carotenoids are inversely associated with breast cancer risk among Chinese women: a case-control study.
    Yan B; Lu MS; Wang L; Mo XF; Luo WP; Du YF; Zhang CX
    Br J Nutr; 2016 Jan; 115(1):129-37. PubMed ID: 26482064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China.
    Yuan JM; Ross RK; Chu XD; Gao YT; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):767-73. PubMed ID: 11440962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A European multicentre, placebo-controlled supplementation study with alpha-tocopherol, carotene-rich palm oil, lutein or lycopene: analysis of serum responses.
    Olmedilla B; Granado F; Southon S; Wright AJ; Blanco I; Gil-Martinez E; van den Berg H; Thurnham D; Corridan B; Chopra M; Hininger I
    Clin Sci (Lond); 2002 Apr; 102(4):447-56. PubMed ID: 11914107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticarcinogenic effect of common carotenoids.
    Gerster H
    Int J Vitam Nutr Res; 1993; 63(2):93-121. PubMed ID: 8407171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer prevention by natural carotenoids.
    Nishino H
    J Cell Biochem Suppl; 1997; 27():86-91. PubMed ID: 9591197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts.
    Michaud DS; Feskanich D; Rimm EB; Colditz GA; Speizer FE; Willett WC; Giovannucci E
    Am J Clin Nutr; 2000 Oct; 72(4):990-7. PubMed ID: 11010942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does beta-carotene explain why reduced cancer risk is associated with vegetable and fruit intake?
    Ziegler RG; Subar AF; Craft NE; Ursin G; Patterson BH; Graubard BI
    Cancer Res; 1992 Apr; 52(7 Suppl):2060s-2066s. PubMed ID: 1544141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiologic evidence for beta-carotene and cancer prevention.
    van Poppel G; Goldbohm RA
    Am J Clin Nutr; 1995 Dec; 62(6 Suppl):1393S-1402S. PubMed ID: 7495237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent preventive action of alpha-carotene against carcinogenesis: spontaneous liver carcinogenesis and promoting stage of lung and skin carcinogenesis in mice are suppressed more effectively by alpha-carotene than by beta-carotene.
    Murakoshi M; Nishino H; Satomi Y; Takayasu J; Hasegawa T; Tokuda H; Iwashima A; Okuzumi J; Okabe H; Kitano H
    Cancer Res; 1992 Dec; 52(23):6583-7. PubMed ID: 1423303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer chemoprevention by carotenoids.
    Tanaka T; Shnimizu M; Moriwaki H
    Molecules; 2012 Mar; 17(3):3202-42. PubMed ID: 22418926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Peters U; Leitzmann MF; Chatterjee N; Wang Y; Albanes D; Gelmann EP; Friesen MD; Riboli E; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):962-8. PubMed ID: 17507623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse carotenoids protect against chemically induced neoplastic transformation.
    Bertram JS; Pung A; Churley M; Kappock TJ; Wilkins LR; Cooney RV
    Carcinogenesis; 1991 Apr; 12(4):671-8. PubMed ID: 2013131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary intake of carotenoids and risk of type 2 diabetes.
    Sluijs I; Cadier E; Beulens JW; van der A DL; Spijkerman AM; van der Schouw YT
    Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):376-81. PubMed ID: 25716098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of beta-carotene in cancer chemoprevention.
    Toma S; Losardo PL; Vincent M; Palumbo R
    Eur J Cancer Prev; 1995 Jun; 4(3):213-24. PubMed ID: 7647689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vegetable-borne lutein, lycopene, and beta-carotene compete for incorporation into chylomicrons, with no adverse effect on the medium-term (3-wk) plasma status of carotenoids in humans.
    Tyssandier V; Cardinault N; Caris-Veyrat C; Amiot MJ; Grolier P; Bouteloup C; Azais-Braesco V; Borel P
    Am J Clin Nutr; 2002 Mar; 75(3):526-34. PubMed ID: 11864859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.